Millennium Management’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-234,000
Closed -$6.35M – 6061
2024
Q4
$6.35M Buy
234,000
+25,000
+12% +$887K ﹤0.01% 2609
2024
Q3
$9.17M Buy
209,000
+126,500
+153% +$4.89M ﹤0.01% 2251
2024
Q2
$3.24M Buy
+82,500
New +$3.39M ﹤0.01% 3120
2024
Q1
– Sell
-70,000
Closed -$2.85M – 6356
2023
Q4
$2.85M Buy
+70,000
New +$4.01M ﹤0.01% 3295

Other funds holding GPCR

Millennium Management's GPCR Position: Q3 2026 in Review

Millennium Management reduced its Structure Therapeutics (GPCR) stake by 9.9% in Q3 2026, selling an estimated $417K and leaving 80,675 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #3702.

Millennium Management first reported a position in GPCR in Q1 2023 and has held it in 15 quarters since. The position peaked at $44.7M in Q2 2024. 171 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Millennium Management held 80,675 shares of Structure Therapeutics worth $2.52M as of Q3 2026.
  • Millennium Management sold 8,893 Structure Therapeutics shares in Q3 2026, an estimated $417K.
  • Structure Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3702 holding.
  • Millennium Management first reported a position in Structure Therapeutics in Q1 2023 and has held it in 15 quarters since.
  • Millennium Management's Structure Therapeutics position peaked at $44.7M in Q2 2024.
  • 171 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.